Marketing of unproven stem cell-based interventions: A call to action.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28679655.
- Also identified by DOI 10.1126/scitranslmed.aag0426.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that has proven resistant to regulatory efforts. Here, we suggest a coordinated approach at the national and international levels focused on engagement, harmonization, and enforcement to reduce the risks associated with direct-to-consumer marketing of unproven stem cell treatments.
Medical subject headings
- Marketing
- Stem Cell Transplantation
- Stem Cells